MARIOTTINI, ALICE
MARIOTTINI, ALICE
Neuroscienze, Area del Farmaco e Salute del Bambino (NEUROFARBA)
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
In corso di stampa Mariottini A, Repice AM, Barilaro A, Massacesi L
Antibody-mediated cell depletion therapies in multiple sclerosis
2022 Mariottini, Alice; Muraro, Paolo A; Lünemann, Jan D
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series
2021 Nicholas R.S.; Rhone E.E.; Mariottini A.; Silber E.; Malik O.; Singh-Curry V.; Turner B.; Scalfari A.; Ciccarelli O.; Sormani M.P.; Olavarria E.; Mehra V.; Gabriel I.; Kazmi M.A.; Muraro P.
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis
2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions
2021 Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study
2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions
2013 Galante, A; Bonechi, E; Mariottini, A; Aldinucci, A; Biagioli, T; Mechi, C; Repice, A; Massacesi, L; Ballerini, C
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
COVID-19 in patients with aggressive MS treated with aHSCT: a multi-center study
2021 E. Sbragia, A. Mariottini, M. Capobianco, S. Martire, L. Moiola, M.P. Amato, L. Massacesi, G. Mancardi, G. Boffa, M. Inglese
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports.
2017 Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A.
Early Morbidity of Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis- A Real World Experience
2021 Varun Mehra, Maria Cuadrado, Elijah Rhone, Alice Mariottini, Victoria Williams, Sarah Ware, Paolo Muraro, Antonio Pagliuca, Victoria Potter, Eli Silber, Majid Kazmi
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis
In corso di stampa Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C,Barilaro A,Massacesi L,Repice A.
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis
2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status
2020 Mariottini, Alice; De Matteis, Eleonora; Muraro, Paolo A.
Immunosenescence and Autoimmunity: Exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis
2021 Amoriello, Roberta; Mariottini, Alice; Ballerini, Clara
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
2021 Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M.
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis
2021 A Mariottini, C Innocenti, G Rastrelli, L Vignozzi, A Giachi, R Saccardi, L Massacesi, A Repice
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis
2016 Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents
2022 Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Luca Massacesi, Paolo Francesconi